OTC Scar Treatment Market
Market Study on OTC Scar Treatment: North America Leads With Over One-third Market Share
OTC Scar Treatment Market Segmented By Topical Scar Products for Atrophic Scars, Hypertrophic Scars and Keloids, Contractures, Burns, Stretch Marks
OTC Scar Treatment Market Outlook (2022-2032)
Worldwide revenue from the OTC scar treatment market reached US$ 8.4 Bn in 2021, with the market estimated to move ahead at a value CAGR of 3.8% to reach a valuation of US$ 12.6 Bn by the end of 2032.
According to Persistence Market Research, sales of topical scar products accounted for US$ 7.4 Bn in 2021. Overall, OTC scar treatment product sales accounted for 68.1% revenue share of the global scar treatment market in 2021.
OTC Scar Treatment Market Size (2022)
US$ 8.7 Bn
Projected Market Value (2032)
US$ 12.6 Bn
Global Market Growth Rate (2022-2032)
Market Share of Top 5 Countries
Find Out More about the Report Coverage
- Smith & Nephew PLC
- Merz Inc.
- Enaltus LLC
- Occulus Innovative Sciences Inc.
- CCA Industries Inc.
- Cynosure Inc
- Avita Medical Limited
- Syneron Medical Ltd.
- Nutramarks Inc.
- Mölnlycke Health Care
- Pacific World Corporation
- Valeant Pharmaceuticals International Inc.
- Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers)
- A. Menarini Singapore Pte. Ltd.
Demand Analysis of OTC Scar Treatment (2012 to 2021) Vs. Market Estimations (2022 to 2032)
The global market for OTC scar treatment exhibited a CAGR of 2.8% over the 2012-2021 historical period.
Despite precautions taken after a trauma or surgical operation, dermal wounds largely heal by scarring, which can have extremely negative effects such as emotional distress, deformity, and reduced standard of living. The fear of stigma and social discomfort among patients with scar tissues emphasizes the importance of developing treatment options to restore scar tissues to healthy skin.
Multiple techniques and methods are effective in the management of scars. However, the growing incidence of scar tissue formation and its consequences on both, function and appearance, continue to place a financial strain on healthcare systems.
Wound treatment significantly increases the expense of healthcare in a nation, in addition to putting a lot of burden on patients and their families. Various therapeutic options exist, but they are often insufficient. Hydrogels are three-dimensional polymeric materials that can withstand considerable swelling without losing structural integrity. These unique properties make them ideal for use as topical wound therapy solutions in the form of films and as vehicles for drug delivery.
The most prevalent type of eczema is atopic dermatitis, a chronic, relapsing inflammatory skin condition characterized by dry skin, constant itching, and scaly lesions. Due to persistent itching and other related issues, including deformity, sleep difficulties, and social stigmatization brought on by visible lesions, this chronic condition significantly affects a patient's quality of life. Topical glucocorticoids, calcineurin inhibitors, and frequent use of moisturizers are the mainstays of atopic dermatitis treatment.
The global OTC scar treatment market is set to expand at 3.8% CAGR and reach a size of US$ 12.6 Bn by the end of 2032.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Why are OTC Scar Treatment Products Gaining Traction?
“Emergence of New Treatment Formulations”
Emollients (moisturizing treatments for direct application on the skin) have recently been enhanced with a variety of potent bioactive compounds to boost epidermal activity. These compounds are being researched more and more as atopic dermatitis treatment and prevention agents. Notably, these additions are grouped as cannabinoid receptor modulators, natural moisturising agents, physiological lipids and ceramide, and antioxidants.
Some active components have effectiveness levels that are on par with low- to medium-potency corticosteroids. These moisturizers with active ingredients also lead to improved treatment compliance, tolerability, and lowered corticosteroid use.
This presents an opportunity for manufacturers to promote their product offerings in the global market and will aid lucrative market growth during the forecasted years. Product adoption and accessibility are key to improving market penetration, and key players in the market are registering novel product portfolios in the market for distribution.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What Can Probably Pull Back Market Expansion?
“Lack of Clinical Data on Product Efficacy”
Dermocosmetics are the subject of an increasing amount of research; however, it is important to remember that there is currently little clinical data supporting them. This is explained by the fact that most clinically tested formulations included a blend of several active ingredients or extracts. The reported efficacy of these multicomponent solutions may not accurately represent the biological action of a single active ingredient, but rather is most likely the result of the synergistic interactions of two or more substances.
A vast majority of the research uses inadequate study designs and limited sample sizes. Systemic examination of data and meta-analysis are both hampered by the absence of consistency in clinical assessment measures.
The lack of clinical data on the efficacy of OTC scar treatment products for a large population base is a restrictive factor for market growth.
Explore Persistence Market Research’s expertise in promulgation of the business !
How is the U.S. OTC Scar Treatment Market Faring?
“Rising Prevalence of Acne Aiding Product Sales”
The U.S. accounted for 85.3% share of the North America OTC scar treatment market in 2021. The U.S. market is expanding as a result of the easy accessibility of topical scar treatment products and growing disposable income in the nation.
- According to the American Academy of Dermatology Association, up to 50 million Americans suffer from acne every year, ranking it as the most prevalent skin condition in the country.
With the easy availability of over-the-counter products to treat acne scars, the U.S. accounts for a large share of the global market for OTC scar treatment medications.
Why is Germany a Lucrative Market for OTC Scar Treatment Providers?
“Growing Research on Natural Compounds and Presence of Established Players”
Germany held 24% share of the Europe OTC scar treatment market in 2021.
The market for OTC scar treatment solutions in the country is expanding as a result of the presence of established manufacturers in Germany. Moreover, with growing epidemiological studies as well as research on the applicability of available biological compounds as ingredients in the form of gels for the treatment of scarring due to dermal conditions, the market is predicted to expand at a steady CAGR of 3.1% over the forecasted years.
What is China’s Stance in the Global Market for OTC Scar Treatment Services?
“Vast Applications of Traditional Chinese Medicine”
China accounted for a market share of 40.4% in the East Asia OTC scar treatment market in 2021 and accounted for 7.4% of the global market share.
- Asian skin has a higher tendency than other skin types to hyperpigment after injury, according to the Chinese expert consensus on clinical prevention and treatment of scars (2018).
Market growth in China is being driven by the presence of several products as a result of the proven efficacy of traditional Chinese medicines for the treatment of skin lesions.
Which OTC Scar Treatment Product is Most Widely Demanded?
“Huge Demand for Topical Scar Products across Regions”
Topical scar products held around 88.1% share of the market for OTC scar treatment in 2021.
Growing demand for non-invasive procedures for the management of scarring as well as rising consumer awareness with respect to available over-the-counter scar treatment products are factors that will drive the topical scar products segment over the forecasted years.
Which OTC Scar Treatment Application Accounts for a Notable Market Share?
“High Prevalence of Acne Causing Atrophic Scars”
Atrophic scars accounted for 38.7% share of the application of OTC scar treatment in 2021.
Atrophic scars mostly occur as a result of acne or diseases such as chicken pox. With a large population suffering from acne, the occurrence of atrophic scars is high as well. This segment thus presents a lucrative opportunity for OTC scar treatment product suppliers.
Key manufacturers of OTC scar treatment products are focusing on promoting their product portfolios through extensive marketing and product penetration strategies. The market for OTC scar treatment products is fragmented and key players are resorting to new product launches to enhance their global market presence.
- SkinCeuticals announced the launch of Advanced Scar Control, its most recent innovation, in September 2021. The new semi-occlusive treatment is intended to shield exposed skin and help scars that have recently healed appear better.
- In July 2019, Dermatix®, a brand of A. Menarini Singapore Pte. Ltd, introduced a new over-the-counter acne scar treatment called Dermatix® Acne Scar.
OTC Scar Treatment Industry Report Scope
Historical Data Available for
USD Million for Value
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon Request
OTC Scar Treatment Industry Research Segmentation
- Topical Scar Products
- Atrophic Scars
- Hypertrophic Scars and Keloids
- Stretch Marks
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
- FAQs -
The global OTC scar treatment market was valued at US$ 8.4 Bn in 2021.
Sales of OTC scar treatment solutions are set to increase at 3.8% CAGR and reach US$ 12.6 Bn by 2032.
Demand for OTC scar treatment increased at 5.1% CAGR from 2012 to 2021.
The U.S., China, Canada, India, and Germany together account for 51.2% market share.
The U.S. accounts for 85.3% share of the North American OTC scar treatment market.
Smith & Nephew PLC, Merz Inc., and Enaltus LLC are the top suppliers of OTC scar treatment products.
China held a share of 40.4% in the East Asia OTC scar treatment market in 2021.
The Indian market is set to exhibit growth at a CAGR of 3.8% during the forecasted years.